Literature DB >> 25461255

Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice.

Mahil Rao1, Teerawit Supakorndej1, Amy P Schmidt1, Daniel C Link2.   

Abstract

The contribution of osteoclasts to hematopoietic stem/progenitor cell (HSPC) retention in the bone marrow is controversial. Studies of HSPC trafficking in osteoclast-deficient mice are limited by osteopetrosis. Here, we employed two non-osteopetrotic mouse models to assess the contribution of osteoclasts to basal and granulocyte colony-stimulating factor (G-CSF)-induced HSPC mobilization. We generated Rank(-/-) fetal liver chimeras using Csf3r(-/-) recipients to produce mice lacking G-CSF receptor expression in osteoclasts. Basal and G-CSF-induced HSPC mobilization was normal in these chimeras. We next acutely depleted osteoclasts in wild-type mice using the RANK ligand inhibitor osteoprotegerin. Marked suppression of osteoclasts was observed after a single injection of osteoprotegerin-Fc. Basal and G-CSF-induced HSPC mobilization in osteoprotegerin-Fc-treated mice was comparable to that in control mice. Together, these data indicate that osteoclasts are not required for the efficient retention of HSPCs in the bone marrow and are dispensable for HSPC mobilization by G-CSF.
Copyright © 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25461255      PMCID: PMC4323843          DOI: 10.1016/j.exphem.2014.10.012

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  16 in total

1.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

2.  Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice.

Authors:  F Liu; H Y Wu; R Wesselschmidt; T Kornaga; D C Link
Journal:  Immunity       Date:  1996-11       Impact factor: 31.745

3.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells.

Authors:  Orit Kollet; Ayelet Dar; Shoham Shivtiel; Alexander Kalinkovich; Kfir Lapid; Yejezkel Sztainberg; Melania Tesio; Robert M Samstein; Polina Goichberg; Asaf Spiegel; Ari Elson; Tsvee Lapidot
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

5.  G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow.

Authors:  Craig L Semerad; Matthew J Christopher; Fulu Liu; Brenton Short; Paul J Simmons; Ingrid Winkler; Jean-Pierre Levesque; Jean Chappel; F Patrick Ross; Daniel C Link
Journal:  Blood       Date:  2005-07-21       Impact factor: 22.113

6.  Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

Authors:  Matthew J Christopher; Fulu Liu; Matthew J Hilton; Fanxin Long; Daniel C Link
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

7.  Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes.

Authors:  Daigo Hashimoto; Andrew Chow; Clara Noizat; Pearline Teo; Mary Beth Beasley; Marylene Leboeuf; Christian D Becker; Peter See; Jeremy Price; Daniel Lucas; Melanie Greter; Arthur Mortha; Scott W Boyer; E Camilla Forsberg; Masato Tanaka; Nico van Rooijen; Adolfo García-Sastre; E Richard Stanley; Florent Ginhoux; Paul S Frenette; Miriam Merad
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

8.  RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats.

Authors:  Michael S Ominsky; Xiaodong Li; Frank J Asuncion; Mauricio Barrero; Kelly S Warmington; Denise Dwyer; Marina Stolina; Zhaopo Geng; Mario Grisanti; Hong-Lin Tan; Timothy Corbin; James McCabe; William S Simonet; Hua Z Ke; Paul J Kostenuik
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

9.  Responses in vivo to purified poly(3-hydroxybutyrate-co-3-hydroxyvalerate) implanted in a murine tibial defect model.

Authors:  Ck A Wu; A R Pettit; S Toulson; L Grøndahl; E J Mackie; A I Cassady
Journal:  J Biomed Mater Res A       Date:  2009-12       Impact factor: 4.396

10.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

Authors:  Isabelle Petit; Martine Szyper-Kravitz; Arnon Nagler; Meir Lahav; Amnon Peled; Liliana Habler; Tanya Ponomaryov; Russell S Taichman; Fernando Arenzana-Seisdedos; Nobutaka Fujii; Judith Sandbank; Dov Zipori; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2002-06-17       Impact factor: 25.606

View more
  8 in total

Review 1.  Cellular players of hematopoietic stem cell mobilization in the bone marrow niche.

Authors:  Joshua Tay; Jean-Pierre Levesque; Ingrid G Winkler
Journal:  Int J Hematol       Date:  2016-12-10       Impact factor: 2.490

Review 2.  Inflammation, fracture and bone repair.

Authors:  Florence Loi; Luis A Córdova; Jukka Pajarinen; Tzu-hua Lin; Zhenyu Yao; Stuart B Goodman
Journal:  Bone       Date:  2016-03-02       Impact factor: 4.398

Review 3.  Osteoimmunology: evolving concepts in bone-immune interactions in health and disease.

Authors:  Masayuki Tsukasaki; Hiroshi Takayanagi
Journal:  Nat Rev Immunol       Date:  2019-06-11       Impact factor: 53.106

Review 4.  The Hematopoietic Niche in Myeloproliferative Neoplasms.

Authors:  Annette H Schmitt-Graeff; Roland Nitschke; Robert Zeiser
Journal:  Mediators Inflamm       Date:  2015-11-30       Impact factor: 4.711

Review 5.  Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche.

Authors:  Evert-Jan F M de Kruijf; Willem E Fibbe; Melissa van Pel
Journal:  Ann N Y Acad Sci       Date:  2019-04-21       Impact factor: 5.691

6.  Granulocyte colony-stimulating factor (G-CSF) mediates bone resorption in periodontitis.

Authors:  Hui Yu; Tianyi Zhang; Haibin Lu; Qi Ma; Dong Zhao; Jiang Sun; Zuomin Wang
Journal:  BMC Oral Health       Date:  2021-06-12       Impact factor: 2.757

7.  Evidence that a lipolytic enzyme--hematopoietic-specific phospholipase C-β2--promotes mobilization of hematopoietic stem cells by decreasing their lipid raft-mediated bone marrow retention and increasing the promobilizing effects of granulocytes.

Authors:  M Adamiak; A Poniewierska-Baran; S Borkowska; G Schneider; A Abdelbaset-Ismail; M Suszynska; A Abdel-Latif; M Kucia; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2015-11-19       Impact factor: 11.528

Review 8.  Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System.

Authors:  Christian Guder; Sascha Gravius; Christof Burger; Dieter C Wirtz; Frank A Schildberg
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.